Hemophagocytic Macrophages and Systemic Salmonella Infection

噬血细胞巨噬细胞和全身性沙门氏菌感染

基本信息

  • 批准号:
    8292621
  • 负责人:
  • 金额:
    $ 18.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-01 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many bacterial pathogens important to human health evade the immune system by living within white blood cells. Salmonella enterica, a species of gram-negative bacteria that includes the causative agent of human typhoid fever, resides within a class of white blood cells called macrophages. We have demonstrated that in mice, S. enterica subspecies Typhimurium (Salmonella) resides and replicates within hemophagocytic macrophages (HM¿), which are macrophages that have engulfed erythrocytes, platelets, leukocytes and their precursor cells. Our long-term goal is to determine how Salmonella and HM¿s interact to cause disease. Mice infected with Salmonella are a natural host-pathogen model system encountered in the wild. Salmonella causes an acute infection in mice that typically resolves into a chronic infection, and the disease course resembles that of typhoid fever. The bacteria colonize the spleen, liver, and the lymph nodes that drain the intestine. We demonstrated the presence of HM¿s within the spleen, liver and bone marrow of Salmonella - infected mice and identified HM¿s containing Salmonella as late as eight weeks post-infection in the liver, when persistent infection has been established. In Preliminary Studies we developed a flow cytometric assay to identify and separate HM¿s from the spleen. This novel methodology along with established approaches enables new exploration of the role of HM¿s in disease. The objectives of the current application are to 1) Determine the immunological requirements for hemophagocytosis and the effect of HM¿ accumulation on the course of murine typhoid fever, 2) Establish whether HM¿s formed in response to Salmonella infection in vivo or in culture become anti-inflammatory and whether anti-inflammatory macrophages are permissive for bacterial replication, and 3) Identify regulatory pathways within HM¿s needed to make them permissive for Salmonella replication. Completion of these Aims has the potential to elucidate whether hemophagocytosis benefits the host as well as Salmonella. In addition, the information we acquire has potential use in the development of treatments that modulate hemophagocytosis and influence the course of inflammation in infectious and non-infectious circumstances. PUBLIC HEALTH RELEVANCE: The work proposed within has the potential to define novel and important mechanisms of host-pathogen interactions not only for Salmonella, but by inference for other microbes that trigger HM¿ accumulation, including Mycobacterium tuberculosis, Leishmania species, and Histoplasma capsulatum. The long-term significance of the proposed work is its potential to suggest novel therapeutic approaches to infectious and non-infectious diseases in which HM¿s accumulate.
描述(由申请人提供):许多对人类健康重要的细菌病原体通过生活在白细胞内逃避免疫系统。肠沙门氏菌是一种革兰氏阴性细菌,包括人类伤寒的病原体,它存在于一类被称为巨噬细胞的白细胞中。我们已经证明,在小鼠中,肠炎沙门氏菌亚种鼠伤寒沙门氏菌(沙门氏菌)在噬血细胞巨噬细胞(HM¿)中存在并复制,噬血细胞巨噬细胞是吞噬红细胞、血小板、白细胞及其前体细胞的巨噬细胞。我们的长期目标是确定沙门氏菌和细菌是如何相互作用导致疾病的。小鼠感染沙门氏菌是在野外遇到的一种自然宿主-病原体模型系统。沙门氏菌在小鼠中引起急性感染,通常会转化为慢性感染,其病程与伤寒相似。这种细菌寄生在脾脏、肝脏和排泄肠道的淋巴结上。我们证实了沙门氏菌感染小鼠的脾脏、肝脏和骨髓中存在HM¿s,并在肝脏感染后8周发现了含有沙门氏菌的HM¿s,此时已经建立了持续感染。在初步研究中,我们开发了一种流式细胞术来鉴定和分离脾脏中的HM¿s。这种新颖的方法以及已建立的方法使人们能够对HM在疾病中的作用进行新的探索。当前应用的目标是:1)确定噬血的免疫学要求以及HM¿积累对小鼠伤寒病程的影响;2)确定体内或培养中因沙门氏菌感染而形成的HM¿s是否具有抗炎作用,以及抗炎巨噬细胞是否允许细菌复制;3)确定HM¿s中允许沙门氏菌复制所需的调节途径。这些目的的完成有可能阐明噬血作用是否对宿主和沙门氏菌有益。此外,我们获得的信息有潜在的用途,在治疗的发展,调节噬血和影响炎症的过程在感染性和非感染性情况下。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Corrella S Detweiler其他文献

Corrella S Detweiler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Corrella S Detweiler', 18)}}的其他基金

Infection-Dependent Vulnerabilities of Gram-negative Bacterial Pathogens
革兰氏阴性细菌病原体的感染依赖性脆弱性
  • 批准号:
    10592676
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
Using Salmonella Pathogenesis and Cell Biology as a Discovery Tool
使用沙门氏菌发病机制和细胞生物学作为发现工具
  • 批准号:
    10665946
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
A Small Molecule That Blocks Salmonella Replication in Macrophages
阻止沙门氏菌在巨噬细胞中复制的小分子
  • 批准号:
    10312125
  • 财政年份:
    2020
  • 资助金额:
    $ 18.54万
  • 项目类别:
Chemical Probes for Bacteria-Macrophage Interactions
用于细菌-巨噬细胞相互作用的化学探针
  • 批准号:
    9171993
  • 财政年份:
    2016
  • 资助金额:
    $ 18.54万
  • 项目类别:
Macrophages, Granulomas, and Bacterial Persistence
巨噬细胞、肉芽肿和细菌持久性
  • 批准号:
    9277403
  • 财政年份:
    2016
  • 资助金额:
    $ 18.54万
  • 项目类别:
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals
一种对哺乳动物无毒的抗菌药物的新型筛选
  • 批准号:
    9186486
  • 财政年份:
    2015
  • 资助金额:
    $ 18.54万
  • 项目类别:
A Novel Screen for Antibacterials that Are Non-Toxic to Mammals
一种对哺乳动物无毒的抗菌药物的新型筛选
  • 批准号:
    9015218
  • 财政年份:
    2015
  • 资助金额:
    $ 18.54万
  • 项目类别:
Host Pathways that Enable /Salmonella/ Replication Within Hemophagocytic Macropha
使/沙门氏菌/在噬血细胞巨噬细胞内复制的宿主途径
  • 批准号:
    8281809
  • 财政年份:
    2012
  • 资助金额:
    $ 18.54万
  • 项目类别:
Host Pathways that Enable /Salmonella/ Replication Within Hemophagocytic Macropha
使/沙门氏菌/在噬血细胞巨噬细胞内复制的宿主途径
  • 批准号:
    8418684
  • 财政年份:
    2012
  • 资助金额:
    $ 18.54万
  • 项目类别:
Hemophagocytic Macrophages and Systemic Salmonella Infection
噬血细胞巨噬细胞和全身性沙门氏菌感染
  • 批准号:
    8805824
  • 财政年份:
    2012
  • 资助金额:
    $ 18.54万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 18.54万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了